297 related articles for article (PubMed ID: 27549395)
41. Defective Connective Tissue Remodeling in Smad3 Mice Leads to Accelerated Aneurysmal Growth Through Disturbed Downstream TGF-β Signaling.
van der Pluijm I; van Vliet N; von der Thusen JH; Robertus JL; Ridwan Y; van Heijningen PM; van Thiel BS; Vermeij M; Hoeks SE; Buijs-Offerman RMGB; Verhagen HJM; Kanaar R; Bertoli-Avella AM; Essers J
EBioMedicine; 2016 Oct; 12():280-294. PubMed ID: 27688095
[TBL] [Abstract][Full Text] [Related]
42. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
43. Differing roles for TGF-β/Smad signaling in osteitis in chronic rhinosinusitis with and without nasal polyps.
Wang M; Ye T; Liang N; Huang Z; Cui S; Li Y; Huang Q; Zhou B
Am J Rhinol Allergy; 2015; 29(5):e152-9. PubMed ID: 26265084
[TBL] [Abstract][Full Text] [Related]
44. Expression of fibroblast growth factors 4, 8, and 10 in limbs, flanks, and blastemas of Ambystoma.
Christensen RN; Weinstein M; Tassava RA
Dev Dyn; 2002 Mar; 223(2):193-203. PubMed ID: 11836784
[TBL] [Abstract][Full Text] [Related]
45. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
46. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
47. The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.
Sun Z; Schriewer J; Tang M; Marlin J; Taylor F; Shohet RV; Konorev EA
J Mol Cell Cardiol; 2016 Jan; 90():129-38. PubMed ID: 26686989
[TBL] [Abstract][Full Text] [Related]
48. Effect of Exogenous Fetuin-A on TGF-
Zhou Y; Yang S; Zhang P
Biomed Res Int; 2016; 2016():8462615. PubMed ID: 27990439
[No Abstract] [Full Text] [Related]
49. CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
Ying Z; Tian H; Li Y; Lian R; Li W; Wu S; Zhang HZ; Wu J; Liu L; Song J; Guan H; Cai J; Zhu X; Li J; Li M
J Clin Invest; 2017 May; 127(5):1725-1740. PubMed ID: 28375158
[TBL] [Abstract][Full Text] [Related]
50. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
51. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.
Ju W; Ogawa A; Heyer J; Nierhof D; Yu L; Kucherlapati R; Shafritz DA; Böttinger EP
Mol Cell Biol; 2006 Jan; 26(2):654-67. PubMed ID: 16382155
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
53. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
54. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
55. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation.
Ferguson CM; Schwarz EM; Reynolds PR; Puzas JE; Rosier RN; O'Keefe RJ
Endocrinology; 2000 Dec; 141(12):4728-35. PubMed ID: 11108288
[TBL] [Abstract][Full Text] [Related]
56. Maternal Smad3 deficiency compromises decidualization in mice.
Zhao KQ; Lin HY; Zhu C; Yang X; Wang H
J Cell Biochem; 2012 Oct; 113(10):3266-75. PubMed ID: 22644778
[TBL] [Abstract][Full Text] [Related]
57. Smad2Δexon3 and Smad3 have distinct properties in signal transmission leading to TGF-β-induced cell motility.
Yokoyama T; Kuga T; Itoh Y; Otake S; Omata C; Saitoh M; Miyazawa K
J Biol Chem; 2023 Feb; 299(2):102820. PubMed ID: 36549646
[TBL] [Abstract][Full Text] [Related]
58. Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line.
Li J; Tang X; Chen X
Exp Eye Res; 2011 Mar; 92(3):173-9. PubMed ID: 21276793
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-activated Smad3-specific dephosphorylation by PP2A.
Heikkinen PT; Nummela M; Leivonen SK; Westermarck J; Hill CS; Kähäri VM; Jaakkola PM
J Biol Chem; 2010 Feb; 285(6):3740-3749. PubMed ID: 19951945
[TBL] [Abstract][Full Text] [Related]
60. Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes.
Liu XJ; Ruan CM; Gong XF; Li XZ; Wang HL; Wang MW; Yin JQ
Biotechnol Lett; 2005 Oct; 27(20):1609-15. PubMed ID: 16245182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
